REAL-WORLD DATA (RWD) / REAL-WORD EVIDENCE (RWE) INSIGHTS

  • Synthetic Control Arms: When Data Stands In For Patients

    Synthetic control arms replace traditional control groups with carefully matched historical or real-world data, offering an option for rare diseases, ethical constraints, or when high-quality datasets exist. They can speed access to treatments, but success depends on rigorous data matching, upfront planning, and early regulatory engagement.

  • Is Double Programming Really Required For Validation?

    Double programming has been the gold standard for validation, but technological advancements and improved sponsor oversight of CRO deliverables have introduced more efficient and reliable alternatives.

RWD/RWE VIDEOS

Explore how clinical trial sponsors can benefit from the growing use of electronic source (eSource) technology at research sites.

Discover how TA Scan’s Trial Feasibility Flex transforms feasibility planning from reactive to proactive—accelerating timelines and reducing risk.

Dr. Andy Liu presents a case study determining which digital measure of physical activity would be a well-defined and reliable clinical endpoint in a trial including patients with diabetes.

Discover a trial feasibility tool that integrates users' operational insights with high-quality clinical intelligence to drive accurate and informed enrollment projections and site capacity analyses.

RWD/RWE RESOURCES